Mocking et al. address the need for enhanced detection of measurable residual disease (MRD) in leukemia utilizing flow cytometry and computational methods. Their fully automated assessment of MRD status produces interpretable results for clinical diagnostic experts.
- Tim R. Mocking
- Angèle Kelder
- Costa Bachas